🇺🇸 FDA
Patent

US 9745314

MDM2 inhibitors and therapeutic methods using the same

granted A61KA61K31/407A61K45/06

Quick answer

US patent 9745314 (MDM2 inhibitors and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/407, A61K45/06, A61P, A61P35/00